BrightOwl Loader Loading

Experiences

Current Experience

  • Clinical Professor of Nuclear Medicine
    Since March 2014
    Director of research at Nuclear Medicine Aalborg (NMA). Chair of NMA Bone Group, a research group dedicated to functional imaging of bone metastasis, particularly in prostate cancer. Professor Lars J. Petersen, MD DMSc CBA, is the author of more than 125 peer-reviewed papers in international journals. He is involved in national and international organizations related to the dedicated research area, including Danish Prostate Cancer Group (DAPROCA), EORTC Imaging Group, EORTC Bone Imaging Group, EuroAIM Evidenced Based Imaging Group,and EIBIR Cancer Imaging.

  • Chief Physician
    Since June 2012
    Previously responsible for clinical nuclear medicine, now fully dedicated to research, see Clinical Professor of Nuclear Medicine.

  • Senior Medical Advisor
    Since January 2008
    Clinical research and medical science expert in KLIFO's Drug Development Council. Primary area is oncology I have worked predominantly in early clinical development with mAbs, NCE, vaccines, and anti-sense products as well as biomarker analyses (including imaging)

  • Director & Owner
    Since August 2005
    Consultancy business providing strategic clinical development assistance to medium to large biotech companies.

Past Experience

  • Medical Director
    August 2015 --- May 2016

  • Professor
    March 2011 --- March 2014
    Professor at Health, Science & Technology from 2011. Moved to the Department of Clinical Medicine, when this department was launched January 1, 2013. Position terminated due to position as Clinical Professor in Nuclear Medicine in 2014.

  • Medical Director
    November 2003 --- July 2005
    Affiliate Medical Director. Recipient of President's Award, the highest award in the company at affilate level for outstanding performance.

  • Associate Medical Director
    August 2001 --- October 2003
    Medical responsible for early drug development for mAbs, mainly in oncology and hematology (primary targets; EGFr, IL-15 & CD-20).

Knowledge

LinkedIn Assessment :
Oncology Clinical ResearchMolecular ImagingDrug DevelopmentoncologyImmunologyClinical trialsPharmaceutical IndustryClinical DevelopmentMedical affairsMedicineGCPClinical researchscienceHematologyHealthcare

Education

  • Certificate in Business Administration (CBA ) in Business Administration & Management from AVT Business School in 2002
  • Doctor of Medical Science (DMSc) in from Københavns Universitet in 1998
  • Physician (MD) in Medicin from Københavns Universitet in 1989
  • Highschool in from Nørre Gymnasium in 1980
  • Elementary school in from Nyager Skole in 1977

Area / Region

Copenhagen, Denmark

Others

Driving License
  • No